96 related articles for article (PubMed ID: 11232291)
1. Structural, biochemical, and biophysical studies of HLA-A2/altered peptide ligands binding to viral-peptide-specific human T-cell receptors.
Baker BM; Ding YH; Garboczi DN; Biddison WE; Wiley DC
Cold Spring Harb Symp Quant Biol; 1999; 64():235-41. PubMed ID: 11232291
[No Abstract] [Full Text] [Related]
2. Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexes.
Biddison WE; Turner RV; Gagnon SJ; Lev A; Cohen CJ; Reiter Y
J Immunol; 2003 Sep; 171(6):3064-74. PubMed ID: 12960332
[TBL] [Abstract][Full Text] [Related]
3. Identification of a crucial energetic footprint on the alpha1 helix of human histocompatibility leukocyte antigen (HLA)-A2 that provides functional interactions for recognition by tax peptide/HLA-A2-specific T cell receptors.
Baker BM; Turner RV; Gagnon SJ; Wiley DC; Biddison WE
J Exp Med; 2001 Mar; 193(5):551-62. PubMed ID: 11238586
[TBL] [Abstract][Full Text] [Related]
4. The structure and stability of an HLA-A*0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site.
Khan AR; Baker BM; Ghosh P; Biddison WE; Wiley DC
J Immunol; 2000 Jun; 164(12):6398-405. PubMed ID: 10843695
[TBL] [Abstract][Full Text] [Related]
5. Not just another Fab: the crystal structure of a TcR-MHC-peptide complex.
Jardetzky T
Structure; 1997 Feb; 5(2):159-63. PubMed ID: 9032079
[TBL] [Abstract][Full Text] [Related]
6. MHC allele-specific molecular features determine peptide/HLA-A2 conformations that are recognized by HLA-A2-restricted T cell receptors.
Wang Z; Turner R; Baker BM; Biddison WE
J Immunol; 2002 Sep; 169(6):3146-54. PubMed ID: 12218132
[TBL] [Abstract][Full Text] [Related]
7. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature. 1996. 384: 134-141.
Garboczi DN; Ghosh P; Utz U; Fan QR; Biddison WE; Wiley DC
J Immunol; 2010 Dec; 185(11):6394-401. PubMed ID: 21084668
[No Abstract] [Full Text] [Related]
8. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2.
Garboczi DN; Ghosh P; Utz U; Fan QR; Biddison WE; Wiley DC
Nature; 1996 Nov; 384(6605):134-41. PubMed ID: 8906788
[TBL] [Abstract][Full Text] [Related]
9. Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures.
Hausmann S; Biddison WE; Smith KJ; Ding YH; Garboczi DN; Utz U; Wiley DC; Wucherpfennig KW
J Immunol; 1999 May; 162(9):5389-97. PubMed ID: 10228016
[TBL] [Abstract][Full Text] [Related]
10. The basis for limited specificity and MHC restriction in a T cell receptor interface.
Piepenbrink KH; Blevins SJ; Scott DR; Baker BM
Nat Commun; 2013; 4():1948. PubMed ID: 23736024
[TBL] [Abstract][Full Text] [Related]
11. T cell receptor recognition via cooperative conformational plasticity.
Gagnon SJ; Borbulevych OY; Davis-Harrison RL; Turner RV; Damirjian M; Wojnarowicz A; Biddison WE; Baker BM
J Mol Biol; 2006 Oct; 363(1):228-43. PubMed ID: 16962135
[TBL] [Abstract][Full Text] [Related]
12. A tale of two T cells.
Janeway CA
Immunity; 1998 Apr; 8(4):391-4. PubMed ID: 9586629
[No Abstract] [Full Text] [Related]
13. Allelic variation of MHC structure alters peptide ligands to induce atypical partial agonistic CD8+ T cell function.
Lim DG; Slavik JM; Bourcier K; Smith KJ; Hafler DA
J Exp Med; 2003 Jul; 198(1):99-109. PubMed ID: 12847139
[TBL] [Abstract][Full Text] [Related]
14. TCR binding to peptide-MHC stabilizes a flexible recognition interface.
Willcox BE; Gao GF; Wyer JR; Ladbury JE; Bell JI; Jakobsen BK; van der Merwe PA
Immunity; 1999 Mar; 10(3):357-65. PubMed ID: 10204491
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive calorimetric investigation of an entropically driven T cell receptor-peptide/major histocompatibility complex interaction.
Armstrong KM; Baker BM
Biophys J; 2007 Jul; 93(2):597-609. PubMed ID: 17449678
[TBL] [Abstract][Full Text] [Related]
16. Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life.
Rubio-Godoy V; Dutoit V; Rimoldi D; Lienard D; Lejeune F; Speiser D; Guillaume P; Cerottini JC; Romero P; Valmori D
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10302-7. PubMed ID: 11517329
[TBL] [Abstract][Full Text] [Related]
17. Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants.
Gagnon SJ; Borbulevych OY; Davis-Harrison RL; Baxter TK; Clemens JR; Armstrong KM; Turner RV; Damirjian M; Biddison WE; Baker BM
J Mol Biol; 2005 Oct; 353(3):556-73. PubMed ID: 16197958
[TBL] [Abstract][Full Text] [Related]
18. Antigenic peptides containing large PEG loops designed to extend out of the HLA-A2 binding site form stable complexes with class I major histocompatibility complex molecules.
Bouvier M; Wiley DC
Proc Natl Acad Sci U S A; 1996 May; 93(10):4583-8. PubMed ID: 8643447
[TBL] [Abstract][Full Text] [Related]
19. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.
Cohen CJ; Sarig O; Yamano Y; Tomaru U; Jacobson S; Reiter Y
J Immunol; 2003 Apr; 170(8):4349-61. PubMed ID: 12682272
[TBL] [Abstract][Full Text] [Related]
20. Rational optimization of tumor epitopes using in silico analysis-assisted substitution of TCR contact residues.
Shang X; Wang L; Niu W; Meng G; Fu X; Ni B; Lin Z; Yang Z; Chen X; Wu Y
Eur J Immunol; 2009 Aug; 39(8):2248-58. PubMed ID: 19593772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
